Merck says will not seek approval of cholesterol treatment

loading...


Merck says will not seek approval of cholesterol treatment
(Reuters) – Merck & Co Inc said on Wednesday it will not seek regulatory approval for its experimental cholesterol drug, anacetrapib, as the clinical profile of the treatment does not support regulatory filings.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...